PFKFB3 gene silencing decreases glycolysis, induces cell-cycle delay and inhibits anchorage-independent growth in HeLa cells

FEBS Letters

Volumn 580, Issue 13, 2006, Pages 3308-3314

  Calvo, M N ^a   Bartrons, R ^a   Castano E ^a   Perales, J C ^a   Navarro Sabate A ^a   Manzano, A ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Anchorage independent growth; Apoptosis; Cell cycle; Glycolysis; PFK 2; pfkfb3; Tumor cell proliferation

Indexed keywords

2,6 BISPHOSPHATASE; 6 PHOSPHOFRUCTO 2 KINASE; ADENOSINE TRIPHOSPHATE; LACTIC ACID; PHOSPHATASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; MESSENGER RNA; PFKFB3 PROTEIN, HUMAN;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL VIABILITY; DRUG EFFECT; GENE SILENCING; GLYCOLYSIS; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; DRUG ANTAGONISM; GENETICS;

CELL CYCLE; GENE SILENCING; GLYCOLYSIS; HELA CELLS; HUMANS; PHOSPHOFRUCTOKINASE-2; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 33746037631     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.04.093     Document Type: Article

References (45)

1. Warburg O. On the origin of cancer cells. Science 123 (1956) 309-314
2. Xu R.H., Pelicano H., Zhou Y., Carew J.S., Feng L., Bhalla K.N., Keating M.J., and Huang P. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res. 65 (2005) 613-621
3. Altenberg B., and Greulich K. Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 84 (2004) 1014-1020
4. Chesney J., Mitchell R., Benigni F., Bacher M., Spiegel L., Al-Abed Y., Han J.H., Metz C., and Bucala R. An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect. Proc. Natl. Acad. Sci. USA 96 (1999) 3047-3052
5. Chiaradonna F., Magnani C., Sacco E., Manzoni R., Alberghina L., and Vanoni M. Acquired glucose sensitivity of k-ras transformed fibroblasts. Biochem. Soc. Trans. 33 (2005) 297-299
6. Wang L. Molecular signaling regulating anchorage-independent growth of cancer cells. Mt. Sinai J. Med. 71 (2004) 361-367
7. Van Schaftingen E., Jett M., Hue L., and Hers H.G. Control of liver 6-phosphofructokinase by fructose 2,6-bisphosphate and other effectors. Proc. Natl. Acad. Sci. USA 78 (1981) 3483-3486
8. Nissler K., Petermann H., Wenz I., and Brox D. Fructose 2,6-bisphosphate metabolism in Ehrlich ascites tumour cells. J. Cancer Res. Clin. Oncol. 121 (1995) 739-745
9. Hirata T., Kato M., Okamura N., Fukasawa M., and Sakakibara R. Expression of human placental-type 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase in various cells and cell lines. Biochem. Biophys. Res. Commun. 242 (1998) 680-684
10. Hue L., and Rousseau G. Fructose 2,6-bisphosphate and the control of glycolysis by growth factors, tumor promoters and oncogenes. Adv. Enzyme Regul. 33 (1993) 97-110
11. Atsumi T., Chesney J., Metz C., Leng L., Donnelly S., Makita Z., Mitchell R., and Bucala R. High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers. Cancer Res. 62 (2002) 5881-5887
12. Rider M.H., Bertrand L., Vertommen D., Michels P.A., Rousseau G.G., and Hue L. 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis. Biochem. J. 381 (2004) 561-579
13. Okar D.A., Manzano A., Navarro-Sabate A., Riera L., Bartrons R., and Lange A.J. PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate. Trends Biochem. Sci. 26 (2001) 30-35
14. Goren N., Manzano A., Riera L., Ambrosio S., Ventura F., and Bartrons R. 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase expression in rat brain during development. Brain Res. Mol. Brain Res. 75 (2000) 138-142
15. Sakakibara R., Uemura M., Hirata T., Okamura N., and Kato M. Human placental fructose-6-phosphate,2-kinase/fructose-2,6-bisphosphatase: its isozymic form, expression and characterization. Biosci. Biotechnol. Biochem. 61 (1997) 1949-1952
16. Navarro-Sabate A., Manzano A., Riera L., Rosa J.L., Ventura F., and Bartrons R. The human ubiquitous 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene (PFKFB3): promoter characterization and genomic structure. Gene 264 (2001) 131-138
17. Kessler R., and Eschrich K. Splice isoforms of ubiquitous 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in human brain. Brain Res. Mol. Brain Res. 87 (2001) 190-195
18. Obach M., Navarro-Sabate A., Caro J., Kong X., Duran J., Gómez M., Perales J.C., Ventura F., Rosa J.L., and Bartrons R. 6-Phosphofructo-2-kinase (pfkfb3) gene promoter contains hypoxia-inducible factor-1 binding sites necessary for transactivation in response to hypoxia. J. Biol. Chem. 279 (2004) 53562-53570
19. Geschwind J.F., Georgiades C., Ko Y.H., and Pedersen P.L. Recently elucidated energy catabolism pathways provide opportunities for novel treatments in hepatocellular carcinoma. Expert Rev. Anticancer Ther. 4 (2004) 449-457
20. Shim H., Chun Y., Lewis B., and Dang C. A unique glucose-dependent apoptotic pathway induced by c-Myc. Proc. Natl. Acad. Sci. USA 95 (1998) 1511-1516
21. Elbashir S.M., Harborth J., Weber K., and Tuschl T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26 (2002) 199-213
22. Burnette W. "Western blotting: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 112 (1981) 195-203
23. Riera L., Manzano A., Navarro-Sabate A., Perales J.C., and Bartrons R. Insulin induces PFKFB3 gene expression in HT29 human colon adenocarcinoma cells. Biochim. Biophys. Acta 1589 (2002) 89-92
24. Gomez M., Manzano A., Navarro-Sabate A., Duran J., Obach M., Perales J.C., and Bartrons R. Specific expression of pfkfb4 gene in spermatogonia germ cells and analysis of its 5′-flanking region. FEBS Lett. 579 (2005) 357-362
25. Van Schaftingen E., Lederer B., Bartrons R., and Hers H.G. A kinetic study of pyrophosphate: fructose-6-phosphate phosphotransferase from potato tubers. Application to a microassay of fructose 2,6-bisphosphate. Eur. J. Biochem. 129 (1982) 191-195
26. Gutmann, I. and Wahlefeld, A.W. (1974) l-(+)-Lactate. In: Bergmeyer, H.U. (Ed.), Methods of Enzymatic Analysis, pp. 1464-1468.
27. Dalmau M., Joaquin M., Nakamura T., Bartrons R., and Gil J. Nitric oxide inhibits DNA synthesis and induces activation of poly(ADP-ribose) polymerase in cultured rat hepatocytes. Exp. Cell Res. 228 (1996) 14-18
28. Van Engeland M., Nieland L., Ramaekers F.C., Schutte B., and Reutelingsperger C.P. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31 (1998) 1-9
29. Hiroi N., Funahashi A., and Kitano H. Comparative studies of suppression of malignant cancer cell phenotype by antisense oligo DNA and small interfering RNA. Cancer Gene Ther. 13 (2006) 7-12
30. Wang Q., and Carmichael G. Effects of length and location on the cellular response to double-stranded RNA. Microbiol. Mol. Biol. Rev. (2004) 432-452
31. Samuel C. Knockdown by RNAi-proceed with caution. Nat. Biotechnol. 22 (2004) 280-282
32. Dahlgren C., Wahlestedt C., and Thonberg H. No induction of anti-viral responses in human cell lines HeLa and MCF-7 when transfecting with siRNA or siLNA. Biochem. Biophys. Res. Commun. 341 (2006) 1211-1217
33. Perez J.X., Roig T., Manzano A., Dalmau M., Boada J., Ventura F., Rosa J.L., Bermudez J., and Bartrons R. Overexpression of fructose 2,6-bisphosphatase decreases glycolysis and delays cell cycle progression. Am. J. Physiol. Cell Physiol. 279 (2000) 1359-1365
34. Dalmau M., Bartrons R., and Gil J. Control of fructose 2,6-bisphosphate metabolism by different mitogenic signals in Swiss 3T3 fibroblasts. Exp. Cell Res. 212 (1994) 93-96
35. Hirata T., Watanabe M., Miura S., Ijichi K., Fukasawa M., and Sakakibara R. Inhibition of tumor cell growth by a specific 6-phosphofructo-2-kinase inhibitor, N-bromoacetylethanolamine phosphate, and its analogues. Biosci. Biotechnol. Biochem. 64 (2000) 2042-2047
36. Aft R.L., Zhang F., and Gius D. Evaluation of 2-deoxy-d-glucose as a chemotherapeutic agent: mechanism of cell death. Br. J. Cancer 87 (2002) 805-812
37. Vander Heiden M.G., Plas D., Rathmell J.C., Fox C.J., Harris M.H., and Thompson C.B. Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol. Cell. Biol. 21 (2001) 5899-5912
38. Maschek G., Savaraj N., Priebe W., Braunschweiger P., Hamilton K., Tidmarsh G.F., De Young L., and Lampidis T.J. 2-Deoxy-d-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo. Cancer Res. 64 (2004) 31-34
39. Boada J., Roig T., Perez X., Gamez A., Bartrons R., Cascante M., and Bermudez J. Cells overexpressing fructose-2,6-bisphosphatase showed enhanced pentose phosphate pathway flux and resistance to oxidative stress. FEBS Lett. 480 (2000) 261-264
40. Izyumov D.S., Avetysian A., Pletjushkina O.Y., Sakharov D.V., Wirtz K.W., Chernyak B.V., and Skulachev V.P. Wages of fear: transient threefold decrease in intracellular ATP level imposes apoptosis. Biochim. Biophys. Acta 1658 (2004) 141-147
41. Darville M.I., and Rousseau G. E2F-dependent mitogenic stimulation of the splicing of transcripts from an S phase-regulated gene. Nucleic Acids Res. 25 (1997) 2759-2765
42. Pozuelo Rubio M., Peggie M., Wong B.H., Morrice N., and MacKintosh C. 14-3-3s regulate fructose-2,6-bisphosphate levels by binding to PKB-phosphorylated cardiac fructose-2,6-bisphosphate kinase/phosphatase. EMBO J. 22 (2003) 3514-3523
43. Masters S.C., Subramanian R.R., Truong A., Yang H., Fujii K., Zhang H., and Fu H. Survival-promoting functions of 14-3-3 proteins. Biochem. Soc. Trans. 30 (2002) 360-365
44. Kim J.W., and Dang C.V. Multifaceted roles of glycolytic enzymes. Trends Biochem. Sci. 30 (2005) 142-150
45. Kim J.W., Zeller K.I., Wang Y., Jegga A.G., Aronow B.J., O'Donnell K.A., and Dang C.V. Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays. Mol. Cell. Biol. 24 (2004) 5923-5936